{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:26:16Z","timestamp":1759778776179,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.arcmed.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T03:02:12Z","timestamp":1438398132000},"page":"454-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Non-Hodgkin Lymphomas: Impact of Rituximab on Overall Survival of Patients with Diffuse Large B-Cell and Follicular Lymphoma"],"prefix":"10.1016","volume":"46","author":[{"given":"Jos\u00e9 Carlos","family":"Jaime-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Magdalena","family":"Gamboa-Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"V\u00e1zquez-Mellado de Larracoechea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisol","family":"Rodr\u00edguez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar Homero","family":"Guti\u00e9rrez-Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Javier","family":"Marfil-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"G\u00f3mez-Almaguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2015.07.004_bib1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2015.07.004_bib2","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1038\/sj.onc.1207843","article-title":"The epidemiology of non-Hodgkin's lymphoma","volume":"23","author":"Fisher","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.arcmed.2015.07.004_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clml.2011.03.012","article-title":"Outcome of diffuse large B-cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data","volume":"11","author":"Komrokji","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.arcmed.2015.07.004_bib4","first-page":"1448","article-title":"[Analysis of clinical features and prognostic factors in 59 cases of follicular lymphoma]","volume":"21","author":"Zhang","year":"2013","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.arcmed.2015.07.004_bib5","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1200\/JCO.1991.9.8.1500","article-title":"Socioeconomic status and cancer survival","volume":"9","author":"Cella","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2015.07.004_bib6","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2013-07-517110","article-title":"Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era","volume":"123","author":"Tao","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2015.07.004_bib7","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/cncr.28549","article-title":"Insurance status is related to diffuse large B-cell lymphoma survival","volume":"120","author":"Han","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.arcmed.2015.07.004_bib8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00277-013-1980-1","article-title":"Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry","volume":"93","author":"van der Poel","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.arcmed.2015.07.004_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1179\/1607845412Y.0000000006","article-title":"Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin's lymphoma in a developing country?","volume":"17","author":"Ruiz-Delgado","year":"2012","journal-title":"Hematology"},{"key":"10.1016\/j.arcmed.2015.07.004_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3960\/jslrt.53.121","article-title":"Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphoma","volume":"53","author":"Tomita","year":"2013","journal-title":"J Clin Exp Hematol"},{"key":"10.1016\/j.arcmed.2015.07.004_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003495-200363080-00005","article-title":"Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia","volume":"63","author":"Plosker","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.arcmed.2015.07.004_bib12","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2015.07.004_bib13","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.arcmed.2015.07.004_bib14","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.arcmed.2015.07.004_bib15","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1182\/blood-2012-07-440073","article-title":"Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases","volume":"120","author":"Laurini","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2015.07.004_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0579.2004.00340.x-i1","article-title":"The therapeutic use of rituximab in non-Hodgkin's lymphoma","volume":"67","author":"Marcus","year":"2007","journal-title":"Eur J Haematol Suppl."},{"key":"10.1016\/j.arcmed.2015.07.004_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2015.07.004_bib18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.arcmed.2015.07.004_bib19","first-page":"419","article-title":"Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women","volume":"15","author":"Zhang","year":"2004","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.arcmed.2015.07.004_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/0971-5851.125250","article-title":"Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: a multicenter registry based study from India","volume":"34","author":"Nimmagadda","year":"2013","journal-title":"Indian J Med Paediatr Oncol"},{"key":"10.1016\/j.arcmed.2015.07.004_bib21","first-page":"194","article-title":"Rituximab and escalated chemotherapy in elderly patients with aggressive diffuse large-cell lymphoma: a controlled clinical trial","volume":"22","author":"Aviles","year":"2007","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.arcmed.2015.07.004_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.beha.2011.02.009","article-title":"Rituximab resistance","volume":"24","author":"Rezvani","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.arcmed.2015.07.004_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4143\/crt.2013.45.2.112","article-title":"Clinical outcome of rituximab-based therapy (RCHOP) in diffuse large B-cell lymphoma patients with bone marrow involvement","volume":"45","author":"Kang","year":"2013","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.arcmed.2015.07.004_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-8722-2-14","article-title":"R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature","volume":"2","author":"Siddhartha","year":"2009","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.arcmed.2015.07.004_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/11591160-000000000-00000","article-title":"Cost effectiveness of rituximab for non-Hodgkin's lymphoma: a systematic review","volume":"30","author":"Auweiler","year":"2012","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.arcmed.2015.07.004_bib26","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3324\/haematol.2011.056531","article-title":"A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype","volume":"97","author":"Wilson","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.arcmed.2015.07.004_bib27","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1179\/102453312X13336169156014","article-title":"New developments in the management of diffuse large B-cell lymphoma","volume":"17 Suppl 1","author":"Habermann","year":"2012","journal-title":"Hematology"},{"key":"10.1016\/j.arcmed.2015.07.004_bib28","first-page":"332","article-title":"[Clinical outcome of autologous stem cell transplantation as first-line treatment in 30 patients with high risk lymphoblastic lymphoma]","volume":"35","author":"Huang","year":"2014","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.arcmed.2015.07.004_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1600-0609.2002.01542.x","article-title":"Combined therapy in advanced stages (III and IV) of follicular lymphoma increases the possibility of cure: results of a large controlled clinical trial","volume":"68","author":"Aviles","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.arcmed.2015.07.004_bib30","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/10428190410001667712","article-title":"Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome","volume":"45","author":"Aviles","year":"2004","journal-title":"Leuk Lymphoma"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440915002040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440915002040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:44:07Z","timestamp":1759261447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440915002040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0188440915002040"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2015.07.004","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-Hodgkin Lymphomas: Impact of Rituximab on Overall Survival of Patients with Diffuse Large B-Cell and Follicular Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}